Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 28, 2024	Jun. 30, 2023
Cash Flows From Operating Activities
Net loss	$ (84,723)	$ (19,644)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	1,967	1,051
Depreciation and amortization	8,199	8,549
Equity in loss (earnings) of unconsolidated joint ventures	1,591	(6,993)
Return on investment in unconsolidated joint ventures	421	11,437
Gain on sale of assets	(3,714)	(1,680)
Other	1,478	409
Changes in operating assets and liabilities:
Accounts receivable, net	5,659	(4,797)
Contract assets	7,996	(9,823)
Accounts payable	(24,508)	9,274
Contract liabilities	(3,963)	(34,156)
Accrued salaries, wages and benefits	1,699	(427)
Accrued expenses	5,176	(19,336)
Other assets and liabilities	3,874	5,464
Net cash used in operating activities	(78,848)	(60,672)
Cash Flows From Investing Activities
Purchases of property, plant and equipment	(7,595)	(3,210)
Proceeds from sale of assets	11,037	4,881
Proceeds from advance on sale of non-core business contracts	0	20,000
Unconsolidated joint venture equity contributions	(3,460)	(13,310)
Return of investments in unconsolidated joint ventures	0	4,286
Net cash (used in) provided by investing activities	(18)	12,647
Cash Flows From Financing Activities
Borrowings on Credit Facility	54,200	0
Net (repayments of) borrowings on Revolving Credit Facility	(14,675)	30,000
Other	(1,691)	(955)
Net cash provided by financing activities	37,834	29,045
Net decrease in cash, cash equivalents and restricted cash	(41,032)	(18,980)
Cash, cash equivalents and restricted cash, beginning of period	63,910	82,085
Cash, cash equivalents and restricted cash, end of period	22,878	63,105
Reconciliation of cash, cash equivalents and restricted cash to the Condensed Consolidated Balance Sheets
Cash and cash equivalents	22,381	61,295
Restricted cash	497	1,810
Total cash, cash equivalents and restricted cash	$ 22,878	$ 63,105